Risankizumab
Generic name: Risankizumab
Drug class:
Interleukin inhibitors
Usage of Risankizumab
Risankizumab is used alone or in combination in adults to treat moderate to severe plaque psoriasis and active psoriatic arthritis.
Risankizumab is also used in adults to treat Crohn's disease.
Risankizumab may also be used for purposes not listed in this medication guide.
Risankizumab side effects
Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.
You may get infections more easily, even serious or fatal infections. Call your doctor right away if you have signs of infection such as:
Also call your doctor at once if you have:
Further doses may be delayed until your infection clears up.
Common side effects of risankizumab may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Risankizumab
You should not use risankizumab if you are allergic to it.
Before you start using risankizumab, tell your doctor if you have any signs of infection such as fever, chills, cough, body aches, tiredness, open sores, or skin wounds, diarrhea, stomach pain, weight loss, painful urination, or coughing up blood.
Tell your doctor if you've had or been exposed to tuberculosis, or if you recently traveled. Some infections are more common in certain parts of the world, and you may have been exposed during travel.
Tell your doctor if you have or ever had:
Make sure you are current on all vaccines before you start using risankizumab.
It is not known if risankizumab will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
If you are pregnant, your name may be listed on a pregnancy registry to track the effects of risankizumab on the baby.
Ask a doctor if it is safe to breastfeed while using risankizumab.
Relate drugs
- Actemra
- Actemra ACTPen
- Adbry
- Arcalyst
- Cosentyx
- Basiliximab
- Benralizumab
- Brodalumab
- Canakinumab
- Cinqair
- Daclizumab
- Dupilumab
- Dupixent
- Dupixent Pre-filled Pen
- Dupixent Pre-filled Syringe
- Enspryng
- Fasenra
- Fasenra Pen
- Fasenra Prefilled Syringe
- Guselkumab
- Ilaris
- Ilumya
- Ixekizumab
- Mepolizumab
- Nucala
- Reslizumab
- Rilonacept
- Risankizumab
- Risankizumab-rzaa
- Satralizumab
- Satralizumab-mwge
- secukinumab
- Siliq
- Siltuximab
- Simulect
- Skyrizi
- Skyrizi Pen
- Spesolimab
- Spesolimab-sbzo
- Spevigo
- Stelara
- Sylvant
- Taltz
- Tildrakizumab
- Tildrakizumab-asmn
- Tocilizumab
- Tralokinumab
- Tralokinumab-ldrm
- Tremfya
- Ustekinumab
- Zinbryta
How to use Risankizumab
Usual Adult Dose for Plaque Psoriasis:
150 mg (two 75 mg injections) suBCutaneously at Week 0, Week 4, and every 12 weeks thereafterComments:-Evaluate patients for tuberculosis (TB) infection prior to initiating this drug.Use: For the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy
Warnings
You may get infections more easily, even serious or fatal infections. Call your doctor if you have flu symptoms, cough, night sweats, neck stiffness, confusion, or vision problems. Before you use risankizumab, your doctor should test you for tuberculosis or other infections.
What other drugs will affect Risankizumab
Other drugs may affect risankizumab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions